Xeris Pharmaceuticals | XERS - PE Price to Earnings


Xeris Pharmaceuticals reported 76.05 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 24.4 1.13 Dec/2025
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 59.75 6.76 Mar/2026
Eli Lilly 40.27 0.06 Mar/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 12.01 222.99 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pacira 38.58 14.1 Mar/2026
Perrigo 27.45 31.51 Mar/2026
Pharma Mar 19.13 1.72 Mar/2026
Qiagen NV 20.54 0.1 Dec/2025
Sartorius 43.44 84.64 Mar/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
Tilray 11.56 80.19 Sep/2025
Zealand Pharma A/S 5.13 0.16 Dec/2025
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026